A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
for Severe Asthma
Drug: Frevecitinib
Sites in Brandon, Tampa +12 more locations
Sponsor: Kinaset Therapeutics Inc
Sex: All·Age: 18 - 75
Code: NCT07532265·Phase 2·Recruiting·Listed Apr 2026